ArticleJournal of biophotonics2025
A Novel Approach to Sequential Organ Failure Assessment (SOFA) Using Near-Infrared Spectroscopy in Extracorporeal Membrane Oxygenation (ECMO) Patients.
Article in Journal of biophotonics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Extracorporeal membrane oxygenation (ECMO) is a medical device that provides temporary external circulation and respiratory support during heart-lung procedures, substituting for heart and lung function to alleviate their burden and allow more time for treatment. This study employs the sequential organ failure assessment (SOFA) to evaluate the severity of illness in ECMO patients and utilizes noninvasive near-infrared spectroscopy (NIRS) to monitor lower limb microcirculation. By extracting and selecting features, blood oxygen information is input into machine learning models for classification and regression analysis. The results indicated that the classification accuracy for disease severity reached 90% for veno-venous (VV-ECMO) and veno-arterial (VA-ECMO) patients, demonstrating the efficacy of combining NIRS with machine learning in clinically distinguishing disease severity. Additionally, the regression analysis yielded excellent performance. These findings underscore the effectiveness of NIRS in assessing disease severity among ECMO patients, offering valuable clinical guidance for optimizing ECMO settings, adjusting cardiovascular medication dosages, and predicting patient prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.